Literature DB >> 32613482

LncRNA SNHG6 promotes LMO3 expression by sponging miR-543 in glioma.

Yin Zhang1, Jiayin An2, Yuchun Pei3.   

Abstract

Small nucleolar RNA host gene 6 (SNHG6) was a newly discovered long non-coding RNA, which was involved in the occurrence and development of a variety of cancers and was on the rise in human cancers. However, the molecular mechanism of SNHG6 in glioma required further investigation. The levels of SNHG6, microRNA-543 (miR-543) and LIM-only protein 3 (LMO3) were detected in glioma tissues and cells by quantitative real-time polymerase chain reaction. We examined cell proliferation and apoptosis rate by methylthiazolyldiphenyl-tetrazolium bromide and flow cytometry assays, respectively. Transwell assay was used to measure cell migration and invasion. The target relationships were predicted by StarBase v.2.0 and TargetScan and confirmed by dual-luciferase reporter assay. Spearman's test was adopted for expression correlation of SNHG6, miR-543 and LMO3 in tissues. The protein expression level of LMO3 was assessed by western blot. We found that SNHG6 was obviously upregulated in glioma tissues and cells. SNHG6 knockdown significantly repressed glioma cell proliferation, migration and invasion, and induced apoptosis. Additionally, SNHG6 directly targeted miR-543 and their expression was negatively correlated in glioma tissues. And miR-543 targeted LMO3 and their expression was also inversely correlated. We found that silencing LMO3 also inhibited the progression of glioma cells. Importantly, SNHG6 could competitively sponging miR-543 thereby modulating LMO3 in glioma cells. SNHG6 served as an oncogene and played a vital role in glioma development through miR-543/LMO3 axis.

Entities:  

Keywords:  Cell progress; Glioma; LMO3; SNHG6; miR-543

Year:  2020        PMID: 32613482     DOI: 10.1007/s11010-020-03772-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  4 in total

1.  LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.

Authors:  Yufei Lv; Xiaohong Lv; Huike Yang; Xiuying Qi; Xiangchen Wang; Chao Li; Xiaochen Shang; Hongmin Guo; Jianguo Zhang; Yafang Zhang
Journal:  Front Oncol       Date:  2021-05-07       Impact factor: 6.244

2.  LMO3 promotes proliferation and metastasis of papillary thyroid carcinoma cells by regulating LIMK1-mediated cofilin and the β-catenin pathway.

Authors:  Zeyi Ling; Xiaoli Long; Ying Wu; Jie Li; Mingliang Feng
Journal:  Open Med (Wars)       Date:  2022-03-07

3.  Exosomal miR-543 Inhibits the Proliferation of Ovarian Cancer by Targeting IGF2.

Authors:  Shupei Zhang; Diling Pan; Shaoyu Zhang; Qiumei Wu; Lan Zhen; Shihuang Liu; Jingjing Chen; Rong Lin; Qiuhua Hong; Xiangqin Zheng; Huan Yi
Journal:  J Immunol Res       Date:  2022-03-29       Impact factor: 4.818

4.  Bioinformatics Profiling and Experimental Validation of 4 Differentially-Expressed LIM Genes in the Course of Colorectal-Adenoma-Carcinoma.

Authors:  Ying He; Zongfu Pan; Qian Shi; Xilin Zhang; Weiyun Shen; Lixia Huo; Huihui Guo; Chengwu Tang; Yuhang Ling
Journal:  Med Sci Monit       Date:  2022-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.